Peña BV, Arjona RIA, Espronceda SK, López FLH, Rodríguez NLM

Language: Spanish
References: 22
Page: 148-154
PDF size: 469.72 Kb.

ABSTRACT

Introduction: The diagnosis and interventional treatment is a distance service in the developing world, in hospitals that do not have interventional cardiology services. This is the case of the Calixto Garcia Hospital, where patients are referred to two nearby hospitals.
Objectives: To characterize the interventional treatment of patients admitted to the coronary care ward of the above hospital.
Method: A descriptive crosssectional study was conducted from January 2003 to December 2009. The medical records and the databases of the Cardiac Catheterization and Interventional Cardiology Departments from the Institute of Cardiology and Cardiovascular Surgery and the Carlos J. Finlay Military Hospital were reviewed.
Results: 841 coronary angiograms were performed. There was a predominance of males with 559 cases (66.5 %), the mean age was 58 years, the most common risk factors included hypertension 613 (72.9%), smoking 277 (32.9%), dyslipidemia 164 (19.5%) and diabetes mellitus 138 (16.4%). Angiographically significant lesions were found in 65% of patients; 272 patients (32.3%) had 1-vessel disease and 276 (32.8%) had 2 and 3-vessel disease. A total of 327 (38.9%) coronary angioplasties were performed, predominantly in men 239 (73%), with a similar behavior of the risk factors. The most common clinical diagnoses in this group included acute coronary syndrome without ST segment elevation 145 (44.3%), chronic stable angina 106 (32.4%) and acute coronary syndrome with ST segment elevation 61 (18.7 %). The most affected and treated artery was the left anterior descending artery. The 3.0 x 18 mm metal stent Apolo was the most used stent. The procedure was successful in 95.7 % of cases.
Conclusions: Percutaneous treatment is a valid option for patients admitted to cen-ters that do not have the interventional cardiology service.

REFERENCES

1. Boden WE, O´Rourke RA, Teo KK, Hartigan PM, Ma-ron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-16.

2. Sanagua JO, Acosta G, Rasmussen R. La rehabilita-ción cardiaca como prevención secundaria. 1er Congreso Virtual de Cardiología. [Artículo en inter-net]. [Citado 2013 Jul 12]. Disponible en: http://www.fac.org.ar/cvirtual/cvirtesp/cientesp/ceesp/cem3901c/csanagua/csanagua.htm

3. Ramos HL. Infarto agudo del miocardio en los cen-tros médicos de diagnóstico integral. Revista elec-trónica de Portales Médicos.com [Internet]. 2008 [citado 2013 May 11];III(19):329 [aprox. 13 p.]. Disponible en: http://www.portalesmedicos.com/publicaciones/articles/1303/1/Infarto-agudo-del-miocardio-en-los-centros-medicos-de-diagnostico-integral.html

4. Gomiz R, Céspedes LA, Castañes JF. Infarto agudo del miocardio. En: Álvarez Sintes R. Temas de Me-dicina General Integral. Vol. II. La Habana: Ciencias Médicas, 2001; p. 546-55.

5. Alfonso JC. El descenso de la fecundidad en Cuba: de la primera a la segunda transición demográfica. Rev Cubana Salud Pública [Internet]. 2006 [citado 2013 May 11];32(1):[aprox. 19 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-34662006000100002&script=sci_arttext

6. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated micro-angiopathy, hypertension, and insulin resistance. Circulation. 2004;109(21):2529-35.

7. Zhang Y, Galloway Y, Welty T, Wiebers D, Whisnant J, Devereux R, et al. Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation. 2008;118(15):1577-84.

8. McAdam B, Byrne D, Morrow j, Oates J. Contribu-tion of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation. 2005;112(7):1024-9.

9. World Health Organization. Tobacco Free Initiative: Why tobacco is a public health priority? [Internet]. [citado 2013 Jun 13]. Disponible en: http://www.who.int/tobacco/health_priority/en/

10. 10.Braunwald E. Tratado de cardiología: Texto de Me-dicina Cardiovascular. 7ma ed. Madrid: Elsevier Saunders; 2006.

11. 11.Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Cir-culation. 2005;112(5):658-65.

12. 12.Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Is-lam S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115(9):1067-74.

13. 13.González-Clemente JM, Palma S, Arroyo J, Vilardell C, Caixás A, Giménez-Palop O, et al. ¿La diabetes mellitus es un equivalente de riesgo coronario? Resultados de un metaanálisis de estudios prospec-tivos. Rev Esp Cardiol. 2007;60(11):1167-76.

14. 14.Rigo F, Frontera J, Llobera J, Rodríguez T, Borrás I, Fuentespina E. Prevalencia de factores de riesgo cardiovascular en las Islas Baleares (estudio CORSAIB). Rev Esp Cardiol. 2005;58(12):1411-9.

15. 15.Masiá R, Sala J, Rohlfs I, Piulats R, Manresa JM, Marrugat J, et al. Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudio REGICOR. Rev Esp Cardiol. 2004;57(3):261-4.

16. 16.Núñez García MV, Ferrer Arrocha M, Meneau Peña TX, Cabalé Vilariño MB, Gómez Nario O, Miguelez Nodarse R. Factores de riesgo aterogénico en la población de 19 a 39 años de 2 consultorios del médico de familia. Rev Cubana Invest Biomed [In-ternet]. 2007 [citado 2013 Jun 17];26(2):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002007000200006

17. 17.Contreras-Solís RE, Rendón-Aguilar P, Tufiño-Oliva-res ME, Levario-Carrillo M, Uranga-Urías TM. Facto-res de riesgo cardiovascular en población adulta de la Unidad de Medicina Familiar de Meoqui, Chih. Rev Mex Cardiol. 2008;19(1):7-15.

18. 18.Miranda AJ, Hernández LL. Presencia de factores de riesgo coronarios en una localidad de Belice. Rev Cubana Med Gen Integr [Internet]. 2006 [citado 2013 Jun 17];22(2):[aprox. 11 p.]. Disponible en: http://www.bvs.sld.cu/revistas/mgi/vol22_2_06/mgi13206.htm

19. 19.Mendoza Beltrán FC, Isaza Restrepo D, Beltrán Pi-neda R, Jaramillo Villegas C, Beltrán Bohórquez JR, Herrera Bertel MA, et al. Guías Colombianas de Cardiología. Síndrome coronario agudo sin eleva-ción del ST (Angina inestable e infarto agudo del miocardio sin elevación del ST). Rev Colomb Car-diol. 2008;15(3):141-232.

20. 20.The TIMI IIIB Investigators. Effects of tissue plasmi-nogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Circulation. 1994;89(4):1545-56.

21. 21.Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and ear-ly invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarc-tion. J Am Coll Cardiol. 1995;26(7):1643-50.

22. 22.Baz José A, Albarrán Agustín, Pinar Eduardo, Mauri Josepa. Registro Español de Hemodinámica y Car-diología Intervencionista. XVIII Informe Oficial de la Sección de Hemodinámica y Cardiología Interven-cionista de la Sociedad Española de Cardiología (1990-2008). Rev Esp Cardiol. 2009;62(12):1418-34.